This study looks at how well a medicine called talquetamab works and how safe it is for people with relapsed or refractory multiple myeloma, a type of blood cancer that comes back or does not respond to treatment. People can join if they have been diagnosed with multiple myeloma and meet certain health tests. You can't join if you've had some special cancer treatments recently or certain health issues like strokes.
Key Points:
- The study involves taking a medicine called talquetamab at a specific dose.
- Participants must follow specific rules and health checks throughout the study.
- Some recent treatments or health problems could keep you from joining.
How understandable was the trial content above?
Hard to understand
Easy to understand